Cannabis Stocks Archives - Page 4 of 16

FridayJan 10, 2025 10:00 am

Medical Cannabis Patients in Arkansas Reach Record Numbers

Voters in Arkansas approved a measure to legalize medical marijuana in 2016 and the state finally began sales in mid-2019 with about 11,000 registered medical marijuana patients. Arkansas’s medical cannabis program has expanded significantly in the years since as more patients registered, reaching 101,006 active MMJ cards in June 2024 and 108,957 by the end of the year. The Arkansas Department of Health is charged with issuing MMJ cards in the state, while the Alcohol and Beverage Control Agency issues licenses to medical cannabis dispensaries. Data shows that post-traumatic stress disorder (PTSD) was the most common medical condition at 34.9%,…

TuesdayJan 07, 2025 10:00 am

Kentuckians Face the Challenge of Choosing Between Gun Ownership and Medical Marijuana

Medical marijuana patients in Kentucky will not have access to guns and ammunition due to federal law. Kentucky's medical marijuana legalization bill was signed into law in March 2023 but took effect on January 1st, 2025, making it legal for approved citizens of the Commonwealth of Kentucky to consume medical-grade cannabis. However, Kentuckians will also have to contend with federal law, which currently outlaws cannabis production and consumption, and how it differs from their state's new medical cannabis law. The U.S. Bureau of Alcohol, Tobacco, Firearms, and Explosives recently sent a letter informing federal firearms licensees that individuals who ‘unlawfully’…

FridayJan 03, 2025 10:00 am

Analysts Observe Sudden Uptick in Cannabis Use as an Alternative to Alcohol

Business analysts have observed a sudden increase in cannabis use as a growing number of Americans turn to cannabis as an alternative to alcohol. According to a recently published Bloomberg Intelligence (BI) survey, Americans are substituting alcohol with cannabis at ‘soaring rates’ as the country's state-level marijuana industry expands. Cannabis has an incredibly complicated history in the U.S. and has been classified as a Schedule I drug, similar to hard drugs like cocaine and heroin, for several decades. However, some studies have found that cannabis is generally safer to consume compared to alcohol. It doesn't impact the human body the…

ThursdayJan 02, 2025 10:00 am

What 2025 Could Hold for Marijuana Firms

The past couple of years have been rough on America's state-level cannabis industry. Cannabis businesses enjoyed healthy demand during the COVID-19 pandemic, particularly in states where cannabis was deemed an essential product, but the industry has been plagued with market oversaturation, low prices, and increasing black market competition in the years since. Investors have been especially wary of putting their funds into the industry, even with a Democratic president at the helm, and could be even more unwilling to invest in the sector under a second Trump presidency. The period of post-pandemic purchasing that was characterized by unusually high demand…

FridayDec 27, 2024 10:00 am

Foreign Companies Could Tap into Germany’s Marijuana Pilot Programs

Non-German companies could potentially benefit from new recreational marijuana pilot programs in Germany, observers say. The European nation partially decriminalized adult-use cannabis on April 1, 2024, becoming the 9th country in the world to legalize cannabis and granting millions of Germans access to the drug. Interestingly, Germany's recreational cannabis measures also allow foreign companies to enter the German market via a cannabis pilot program license. These entities would need approval from the German municipality where they would set up shop. Furthermore, they have to prove that their pilot program had a scientific or experimental component to receive a pilot program…

ThursdayDec 26, 2024 10:00 am

Recent Scientific Findings Altering Our Knowledge about Marijuana

While around one in every five Americans now use marijuana, the understanding of its health effects has historically been limited. However, as regulations surrounding cannabis ease, scientists are gaining new insights into its benefits and risks. Many believe it’s a safe and natural option for managing pain, muscle spasms, nausea, appetite issues, and PTSD. While research supports this, cannabis isn’t as risk-free as some assume. With fewer barriers to conducting research on the drug, scientists are uncovering potential long-term impacts on mental health, the lungs, the digestive system, and the heart. Still, much remains unknown due to limited studies. Let’s…

FridayDec 20, 2024 10:00 am

Ohio’s Recreational Marijuana Market Stands Out as the Only One Launched This Year

In a year that will go down in history as one of the quietest for state-level marijuana market launches in the U.S., Ohio's adult-use market stood out with the only launch of 2024. Ohio debuted its recreational cannabis market on August 6, making it the only state to unveil a new cannabis market in the U.S. this year. This marks a significant departure from a young industry that has gone through non-stop market expansion for more than 10 years. Unfortunately, Ohio's recreational marijuana market launch wasn't as successful as previous launches. The state recorded a sales dip right after it…

ThursdayDec 19, 2024 10:00 am

New York Regulators Consider Limiting the Issuance of Marijuana Retail Licenses

New York state marijuana regulators are considering whether they should temporarily cap the number of marijuana retail licenses to 1,600. According to a statement from Cannabis Advisory Board (CAB) chair Joseph Belluck, the Cannabis Advisory Board sent the suggestion to cap state retail licenses to the Cannabis Control Board (CCB). The CCB’s suggestion is nonbinding and it will be up to the Cannabis Control Board to take steps and facilitate the temporary cap on licenses. New York's regulated cannabis industry is still in its infancy after the state legalized marijuana in March 2021 and began adult-use sales before the end…

TuesdayDec 17, 2024 4:20 pm

420 with CNW — Portugal Looks Forward to Standing Out as a Medical Marijuana Hub

Portugal is rapidly emerging as a leading center for medical marijuana in Europe. Its mild, temperate, subtropical environment, frequently likened to that of California, makes it an excellent location for cultivating cannabis. “No other European country offers better environmental conditions,” said Martins of FAI Therapeutics, a Portuguese pharmaceutical firm. Located near the hills of Serpa, surrounded by cork oaks and olive trees, FAI Therapeutics’ 13.3-acre farm produces approximately 30 tons of marijuana flowers annually. The operation began in 2022 following a surge of interest from international marijuana producers drawn to Portugal’s ideal climate and supportive legislation. Currently, over 60 companies…

TuesdayDec 17, 2024 10:00 am

US Marijuana Research is Witnessing an Evolving Landscape

The nascent cannabis research field recently hit a major milestone after the U.S. Food & Drug Administration (FDA) finally greenlit Phase 2 of the Multidisciplinary Association for Psychedelic Studies (MAPS) study on the feasibility of using smoked cannabis to treat post-traumatic stress disorder (PTSD) in veterans. The authorization came after three years of discussion between the FDA and MAPS. Titled MJP2, the study will test the efficacy and safety of inhaling high-THC cannabis in managing PTSD symptoms in veterans compared to a placebo. Nearly 320 veterans from Michigan and three additional states will take part in the study. The Michigan…